Provided by Tiger Trade Technology Pte. Ltd.

Tempest Therapeutics Inc.

0.7554
-0.0289-3.68%
Pre-market: 1.060.3046+40.32%09:14 EDT
Volume:26.44M
Turnover:30.02M
Market Cap:12.49M
PE:-0.17
High:0.8094
Open:0.7990
Low:0.7432
Close:0.7843
52wk High:12.23
52wk Low:0.7432
Shares:16.54M
Float Shares:11.46M
Volume Ratio:77.43
T/O Rate:230.73%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.5617
EPS(LYR):-19.4955
ROE:-931.14%
ROA:-79.37%
PB:-11.46
PE(LYR):-0.04

Loading ...

Tempest Therapeutics directors Brady, Raab, Pellizzari resign from board

Reuters
·
May 23

Tempest Risk Solutions Appoints David Näslund As CEO

Reuters
·
May 20

Tempest net loss widens 155% to $27.7 million in Q1 2026

Reuters
·
May 15

Tempest Therapeutics Q1 net loss widens on asset acquisition costs

Reuters
·
May 15

Tempest Therapeutics Q1 Operating Income USD -27.719 Million

THOMSON REUTERS
·
May 15

Press Release: Tempest Reports First Quarter 2026 Financial Results and Provides Business Update

Dow Jones
·
May 15

Tempest Therapeutics Inc expected to post a loss of 28 cents a share - Earnings Preview

Reuters
·
May 08

Tempest says TPST-2003 dual-target CAR-T hits 100% complete response in Phase 1 trials

Reuters
·
May 06

Jakarta, Danantara Sign Rp17.4 Trillion Waste-to-Energy Deal

Tempo
·
May 05

Tempest to present TPST-2003 clinical update at ISCT annual meeting

Reuters
·
Apr 29

Tempest Therapeutics provides update on development of TPST-2003

TIPRANKS
·
Apr 22

Tempest Announces Key Manufacturing Milestone for TPST-2003 Dual-Targeting CD19/BCMA CAR-T

GlobeNewswire
·
Apr 22

Press Release: Tempest Appoints Andrew Fang, Ph.D., as Head of Business Development to Advance Strategic Partnerships and Global Licensing Efforts

Dow Jones
·
Apr 14

Tempest Therapeutics Inc - Company Will Not Receive Proceeds From Sale of Shares by Selling Stockholders - SEC Filing

THOMSON REUTERS
·
Apr 02

Tempest Therapeutics Inc - Prospectus Filed for Resale of up to About 2.8 Mln Shares Including Warrants - SEC Filing

THOMSON REUTERS
·
Apr 02

Tempest Therapeutics files to sell 2.78M shares of common stock for holders

TIPRANKS
·
Apr 02

Tempest Therapeutics files to sell 8.27M shares of common stock for holders

TIPRANKS
·
Mar 31

Tempest Therapeutics Inc - Offers up to 8.27 Mln Shares of Common Stock for Resale by Selling Stockholders - SEC Filing

THOMSON REUTERS
·
Mar 31

BRIEF-Tempest Reports Year End 2025 Financial Results And Provides Business Update

Reuters
·
Mar 30

Tempest Therapeutics Inc - Appoints Matt Angel as CEO and President

THOMSON REUTERS
·
Mar 30